TP53 and B-cell chronic lymphocytic leukemia: It should be noted that due to the limited availability of TP53 wild-type CLL cell lines and difficulties in mutation introduction, the acute lymphoblastic leukemia cell line (but B cell precursor leukemia) was used here as a model.